| Product Code: ETC7626394 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sumit Sagar | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Ireland Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Overview |
3.1 Ireland Country Macro Economic Indicators |
3.2 Ireland Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Revenues & Volume, 2021 & 2031F |
3.3 Ireland Chronic Obstructive Pulmonary Disease (COPD) Treatment Market - Industry Life Cycle |
3.4 Ireland Chronic Obstructive Pulmonary Disease (COPD) Treatment Market - Porter's Five Forces |
3.5 Ireland Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Revenues & Volume Share, By Drug Class, 2021 & 2031F |
3.6 Ireland Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.7 Ireland Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Ireland Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of COPD in Ireland |
4.2.2 Growing awareness about COPD and its treatment options |
4.2.3 Technological advancements in COPD treatment |
4.2.4 Rising healthcare expenditure in Ireland |
4.3 Market Restraints |
4.3.1 Stringent regulations and approval processes for COPD treatment drugs |
4.3.2 High costs associated with COPD treatment |
4.3.3 Limited access to specialized healthcare services in remote areas of Ireland |
5 Ireland Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Trends |
6 Ireland Chronic Obstructive Pulmonary Disease (COPD) Treatment Market, By Types |
6.1 Ireland Chronic Obstructive Pulmonary Disease (COPD) Treatment Market, By Drug Class |
6.1.1 Overview and Analysis |
6.1.2 Ireland Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Revenues & Volume, By Drug Class, 2021- 2031F |
6.1.3 Ireland Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Revenues & Volume, By Combination Therapy, 2021- 2031F |
6.1.4 Ireland Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Revenues & Volume, By Bronchodilators, 2021- 2031F |
6.1.5 Ireland Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Revenues & Volume, By Corticosteroids, 2021- 2031F |
6.1.6 Ireland Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Revenues & Volume, By Phosphodiesterase Type 4 Inhibitor, 2021- 2031F |
6.1.7 Ireland Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Revenues & Volume, By Mucokinetics, 2021- 2031F |
6.1.8 Ireland Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Revenues & Volume, By Others, 2021- 2031F |
6.2 Ireland Chronic Obstructive Pulmonary Disease (COPD) Treatment Market, By Type |
6.2.1 Overview and Analysis |
6.2.2 Ireland Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Revenues & Volume, By Chronic Bronchitis, 2021- 2031F |
6.2.3 Ireland Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Revenues & Volume, By Emphysema, 2021- 2031F |
6.3 Ireland Chronic Obstructive Pulmonary Disease (COPD) Treatment Market, By Distribution Channel |
6.3.1 Overview and Analysis |
6.3.2 Ireland Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Revenues & Volume, By Hospital Pharmacies, 2021- 2031F |
6.3.3 Ireland Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Revenues & Volume, By Retail Pharmacies, 2021- 2031F |
6.3.4 Ireland Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Revenues & Volume, By Online Pharmacies, 2021- 2031F |
7 Ireland Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Import-Export Trade Statistics |
7.1 Ireland Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Export to Major Countries |
7.2 Ireland Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Imports from Major Countries |
8 Ireland Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Key Performance Indicators |
8.1 Number of COPD patients diagnosed annually in Ireland |
8.2 Adoption rate of new COPD treatment technologies in healthcare facilities |
8.3 Percentage increase in government funding for COPD treatment programs |
8.4 Average waiting time for COPD patients to receive treatment in Ireland |
8.5 Patient satisfaction scores with COPD treatment services provided |
9 Ireland Chronic Obstructive Pulmonary Disease (COPD) Treatment Market - Opportunity Assessment |
9.1 Ireland Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Opportunity Assessment, By Drug Class, 2021 & 2031F |
9.2 Ireland Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Opportunity Assessment, By Type, 2021 & 2031F |
9.3 Ireland Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Ireland Chronic Obstructive Pulmonary Disease (COPD) Treatment Market - Competitive Landscape |
10.1 Ireland Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Revenue Share, By Companies, 2024 |
10.2 Ireland Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here